Sarin is currently CFO of US rare diseases specialist Alexion, which is in the process of being acquired by AstraZeneca in a $39bn deal.
Image: Dimitris Barletis/Shutterstock.com
Pharmaceutical firm AstraZeneca has named Aradhana Sarin as its next chief financial officer.
The appointment is conditional upon AstraZeneca’s acquisition of US firm Alexion Pharmaceuticals, where Sarin is currently CFO. The deal is expected to be completed later this year.
Sarin will replace Marc Dunoyer, who is stepping down from the AstraZeneca board to become the firm’s chief strategy officer, and will be CEO of Alexion once the takeover is completed.
Sarin was previously managing director, healthcare corporate and investment banking at Citi Global Banking in New York, where she advised clients in the life sciences and bioph
For thoughtful journalism, expert insights on corporate governance and an extensive library of reports, guides and tools to help boards and directors navigate the complexities of their roles, subscribe to Board Agenda